The tuberculin skin test (TST) and the interferon gamma release assay (IGRA) have low ability to discriminate active from latent TB (33–35) and these tests cannot be used to predict whether an individual with LTBI will develop active TB or whether therapy for LTBI could be effective to decrease the risk of developing active TB (36). This evidence concerns the gene IFNG and tuberculosis.